~~<i id='C587184CE5'><strike id='C587184CE5'><tt id='C587184CE5'><pre id='C587184CE5'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

leisure time

author：Wikipedia 2025-08-03 10:43:42 - browse：2272

The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： WATCH: Why do fingernails fall off when they're damaged?

Wikipedia

focus

hotspot

Wikipedia

knowledge

AdobeWhentheHumanGenomeProjectbeganin1990,bioethicistsfearedthatgivingpeopletheresultsofgenetictests

WSS

The battle over the Brookhaven Landfill on Long Island

Illumina to lay off 10% of research and development team

Donald Trump's relentless attacks on special counsel Jack Smith

Do masks work? RCTs can't tell us

The strategy behind pharma's lawsuits over drug pricing reform

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

hotspot

leisure time

Wikipedia

At least 13 dead in Texas as scorching temps continue

Belarusian journalist sentenced to 4 years in prison as crackdown continues

Alkermes shareholders re

3 hurdles to bringing medical devices to the U.S. market

Guidelines to prevent youth baseball injuries need more muscle

ADA: All diabetes patients should be screened for liver condition

Alkermes shareholders re

The simple reason for the increase in autism diagnosis

In Memoriam: Notable people who died in 2023

What Wagner Group's armed rebellion could mean for Russia's endgame in Ukraine

focus

What would happen to your eyes if you looked at the solar eclipse?

STAT's guide to the next generation of CAR

The story of mRNA: From a loose idea to a tool that may help curb Covid

The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

Why do we get seasonal allergies?

focus

hotspot

Wikipedia

knowledge